Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age.

PloS one

Volumn 8, Issue 10, 2013, Pages

  Malkin, Elissa ^a   Yogev, Ram ^b   Abughali, Nazha ^b   Sliman, Joseph ^b   Wang, C Kathy ^b   Zuo, Fengrong ^b   Yang, Chin Fen ^b   Eickhoff, Mark ^b   Esser, Mark T ^b   Tang, Roderick S ^b   Dubovsky, Filip ^b  

^a MEDIMMUNE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; MEDI 559; MEDI-559; RESPIRATORY SYNCYTIAL VIRUS VACCINE; VIRUS ANTIBODY;

ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; FEMALE; HUMAN; IMMUNOLOGY; INFANT; MALE; METHODOLOGY; NOSE OBSTRUCTION; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; TIME; TREATMENT OUTCOME; VACCINATION;

ANTIBODIES, VIRAL; CHILD, PRESCHOOL; COHORT STUDIES; COUGH; FEMALE; HUMANS; INFANT; MALE; NASAL OBSTRUCTION; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUSES; TIME FACTORS; TREATMENT OUTCOME; VACCINATION; VACCINES, ATTENUATED;

EID: 84894048036     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077104     Document Type: Article

References (0)